Overview
Background
Peter Simpson is a recognised expert in the molecular and pathological characterisation of breast and lung cancers. His research is based at the UQ Centre for Clinical Research (UQCCR), where he is the Head of the Cancer Theme and is a Research Group Leader in Cancer Genomics. He has published >150 articles (>12,000 citations, H-index 52; Scopus, May2025) including in Nature, Nature Medicine, Annals of Oncology and the American Journal of Respiratory and Critical Care Medicine. He co-manages the Brisbane Breast Bank (BBB), a tissue bank created to facilitate clinical breast cancer research, and the Debutant lung cancer Program.
Pete also holds a teaching appointment in UQ, where he is passionate about the science and clinical applications of Pathology. He teaches into the UQ Medical Program (Year 1 and 2), as well as to undergraduates. He has co-authored a chapter ‘Breast Diseases’ in the latest edition (11th) of the internationally acclaimed Medical text book Robbins and Cotran Pathologic Basis of Disease.
Outside UQ, Pete is a Fellow of the Faculty of Science in the Royal College of Pathologists of Australasia (FFSc RCPA), a member of the kConFab Executive (https://www.kconfab.org/), a member of the Lobular Breast Cancer Alliance Scientific Advisory Board (https://lobularbreastcancer.org/), and a member of the International Cancer Genome Consortium (Breast Cancer group).
Pete enjoys supervising students at all levels in their careers and collaborating within multidisciplinary teams spanning clinical (e.g. pathology, oncology) and science teams (e.g. in ‘omics, bioinformatics and machine learning).
Availability
- Associate Professor Peter Simpson is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, University of Liverpool
Research interests
-
Broad Research Program
Cancer is a very heterogeneous disease, making morphological classification and management of patients a significant challenge. Despite great advances it remains difficult to predict which patients are at risk of their disease returning (recurrence), spreading (metastasis) or which patients will gain most benefit to specific therapies. There has therefore been a concerted effort to supplement the morphological classification of disease with molecular data that can provide a clearer appreciation for this complexity and better predict tumour behaviour. This ideology has driven significant advancements in the field of molecular pathology research. My research program embraces these advances in technology to help better understand mechanisms of disease development and progression and help improve the molecular aspects of diagnosis and patient management. Themes of research involve 1) invasive lobular carcinoma of the breast, 2) breast cancer diagnosed in young individuals, and 3) lung cancer.
-
Invasive Lobular Carcinoma
Invasive Lobular Carcinoma (ILC) is the most commonly diagnosed ‘special’ morphological type of breast cancer, comprising up to 15% of all cases. The most important biological feature of lobular breast cancer is the functional loss of cell adhesion molecule E-cadherin. This is the glue that holds epithelial cells together. Loss of E-cadherin leads to a growth pattern that can be diffuse and highly invasive through the breast tissue. This leads to a number of important clinical challenges with diagnosing and managing this cancer: the cancer can be hard to palpate or detect by mammographic screening and hard to fully excise during surgery; if the cancer spreads it can again be hard to detect. A large component of Peter's research focuses on aspects of this specific cancer subtype, including understanding molecular determinants that predict tumour behaviour and prognosis, and mechanisms of invasion and metastasis.
-
Familial Breast Cancer
Family history is a significant risk factor for the development of breast cancer, often leading to early diagnosis of disease. For some families, the genetic component of this risk is well understood and attributed to pathogenic germline variants in moderate-high risk genes (e.g. BRCA1, BRCA2, PALB2, TP53, ATM, CHEK2). For many families the underlying genetic risk is unknown. Further, some individuals develop breast cancer at a young age when they have no family history. We study clinical samples using a variety of molecular profiling techniques, including whole genome sequencing and digital spatial transcriptomics, and we are interested in understanding the germline and somatic molecular mechanism that contribute to the development of disease. This work is a collaboration with several tissue banks: kConFab, the BBB and the Australian Breast Cancer Tissue Bank.
-
Lung Cancer Diagnostics
Lung Cancer has the highest mortality of all cancers. Most cases are diagnosed at an advance, inoperable stage and so are associated with a poor prognosis. Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) sampling is an important procedure to make a tissue diagnosis of disease and to provide specimens for molecular testing. Next generation sequencing is an important component of diagnostic practice and therapeutic decision making for lung cancer patients. Our program of work is focused on optimising molecular testing strategies from different types of cancer samples (tissue, supernatant, cfDNA) to improve the success of testing for patients. This is a collaboration with A/Prof David Fielding (https://about.uq.edu.au/experts/9060) from the Department of Thoracic Medicine (RBWH), plus colleagues from Pathology Queensland, QIMR Berghofer and a network of hospitals around Australia.
Research impacts
Breast cancer is the most diagnosed cancer in women worldwide and consequently is the biggest contributor to morbidity and mortality from cancer.
My work in the field of breast cancer genomics has sought to unravel molecular mechanisms driving the evolution of disease, from early lesions through to treatment resistance and metastatic progression. Our work uses various types of ‘omics applications, including whole genome sequencing and spatial transcriptomics, married with detailed cancer morphology assessment. Gene mutations and mutational signature analysis in the context of sporadic and familial breast cancer has revealed pathogenic germline mutations, different mechanisms of genomic evolution and clonal heterogeneity. The work through the International Cancer Genome Consortium contributed to the development of HRDetect (Nature Medicine) for therapeutic decision making.
My work in lobular breast cancer has an international standing. As a research community, we aim to raise the profile of lobular breast cancer as an important, common and yet understudied type of breast cancer. We have demonstrated this disease is in fact a heterogenous subtype, exhibiting morphological variants and diverse genomic features. We developed LobSig as a potential prognostic tool for lobular breast cancer, which is undergoing further validation. We have a program of work to better understand the biology of disease and identify tissue- and blood-based biomarkers of disease progression.
Lung cancer is the highest mortality rate of all cancers worldwide. The Debutant lung cancer clinical research program was established in 2018 and has sought to optimise and expand lung cancer molecular testing applications. The work has been funded by various sources, including Pathology Queensland, Royal Brisbane & Women’s Hospital Foundation, Cancer Council Qld, Cancer Australia, Australian Genomics and the Medical Research Future Fund (MRFF). The work has demonstrated the clinical utility of very small cytology samples and blood (cfDNA) samples using comprehensive genomic assays. The translation of results from this Program could significantly enhance the number of patients eligible for targeted therapies.
Works
Search Professor Peter Simpson’s works on UQ eSpace
2020
Journal Article
Using whole-genome sequencing data to derive the homologous recombination deficiency scores
de Luca, Xavier M., Newell, Felicity, Kazakoff, Stephen H., Hartel, Gunter, McCart Reed, Amy E., Holmes, Oliver, Xu, Qinying, Wood, Scott, Leonard, Conrad, Pearson, John V., Lakhani, Sunil R., Waddell, Nicola, Nones, Katia and Simpson, Peter T. (2020). Using whole-genome sequencing data to derive the homologous recombination deficiency scores. npj Breast Cancer, 6 (1) 33, 33. doi: 10.1038/s41523-020-0172-0
2020
Journal Article
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases
Kalita-de Croft, Priyakshi, Lim, Malcolm, Chittoory, Haarika, de Luca, Xavier M., Kutasovic, Jamie R., Day, Bryan W., Al-Ejeh, Fares, Simpson, Peter T., McCart Reed, Amy E., Lakhani, Sunil R. and Saunus, Jodi M. (2020). Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases. Therapeutic Advances in Medical Oncology, 12 1758835920946259, 175883592094625. doi: 10.1177/1758835920946259
2020
Conference Publication
Designing retrospective analysis of examination items for medical students in clinical science categorisation by Bloom’s Taxonomy, clinical relevance and student perceptions
Li, Joan, Reddy, Venkat, Steele, Megan, Forster, Ashlee, Oancea, Ilulia, Midwinter, Mark, Aland, Claire, Pillai, Suja, Simpson, Peter, Babri, Saleem and Barry, Ben (2020). Designing retrospective analysis of examination items for medical students in clinical science categorisation by Bloom’s Taxonomy, clinical relevance and student perceptions. ANZAHPE2020, Melbourne, VIC Australia, 12-15 July 2020.
2020
Journal Article
Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer
Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Gyorffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O. and Chan, Stephen Y. T. (2020). Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer. JAMA Network Open, 3 (7) e209486, e209486. doi: 10.1001/jamanetworkopen.2020.9486
2020
Journal Article
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
Baker, Laura A., Holliday, Holly, Roden, Daniel, Krisp, Christoph, Wu, Sunny Z., Junankar, Simon, Serandour, Aurelien A., Mohammed, Hisham, Nair, Radhika, Sankaranarayanan, Geetha, Law, Andrew M. K., McFarland, Andrea, Simpson, Peter T., Lakhani, Sunil, Dodson, Eoin, Selinger, Christina, Anderson, Lyndal, Samimi, Goli, Hacker, Neville F., Lim, Elgene, Ormandy, Christopher J., Naylor, Matthew J., Simpson, Kaylene, Nikolic, Iva, O'Toole, Sandra, Kaplan, Warren, Cowley, Mark J., Carroll, Jason S., Molloy, Mark and Swarbrick, Alexander (2020). Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer. Breast Cancer Research , 22 (1) 63, 63. doi: 10.1186/s13058-020-01306-6
2020
Journal Article
Digital spatial profiling application in breast cancer: a user’s perspective
McCart Reed, Amy E., Bennett, James, Kutasovic, Jamie R., Kalaw, Emarene, Ferguson, Kaltin, Yeong, Joe, Simpson, Peter T. and Lakhani, Sunil R. (2020). Digital spatial profiling application in breast cancer: a user’s perspective. Virchows Archiv, 477 (6), 885-890. doi: 10.1007/s00428-020-02821-9
2020
Conference Publication
Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinoma
Simpson, P., Reed, A. McCart, Kutasovic, J., Coorey, C., Kuo, L., Nguyen, H., Pei, W., Ong, J., Sokolova, A., Evans, E., Porter, A. and Lakhani, S. (2020). Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinoma. ESMO Breast Cancer Virtual Meeting, Online, 23-24 May 2020. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2020.03.186
2020
Journal Article
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
Kutasovic, Jamie R., McCart Reed, Amy E., Sokolova, Anna, Lakhani, Sunil R. and Simpson, Peter T. (2020). Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer. Cancers, 12 (4) 848, 848. doi: 10.3390/cancers12040848
2020
Journal Article
Pan-cancer analysis of whole genomes
Campbell, Peter J., Getz, Gad, Korbel, Jan O., Stuart, Joshua M., Jennings, Jennifer L., Stein, Lincoln D., Perry, Marc D., Nahal-Bose, Hardeep K., Ouellette, B. F. Francis, Li, Constance H., Rheinbay, Esther, Nielsen, G. Petur, Sgroi, Dennis C., Wu, Chin-Lee, Faquin, William C., Deshpande, Vikram, Boutros, Paul C., Lazar, Alexander J., Hoadley, Katherine A., Louis, David N., Dursi, L. Jonathan, Yung, Christina K., Bailey, Matthew H., Saksena, Gordon, Raine, Keiran M., Buchhalter, Ivo, Kleinheinz, Kortine, Schlesner, Matthias, Zhang, Junjun ... Hamdy, Freddie C. (2020). Pan-cancer analysis of whole genomes. Nature, 578 (7793), 82-93. doi: 10.1038/s41586-020-1969-6
2020
Journal Article
Genomic basis for RNA alterations in cancer
Calabrese, Claudia, Davidson, Natalie R., Demircioğlu, Deniz, Fonseca, Nuno A., He, Yao, Kahles, André, Lehmann, Kjong-Van, Liu, Fenglin, Shiraishi, Yuichi, Soulette, Cameron M., Urban, Lara, Greger, Liliana, Li, Siliang, Liu, Dongbing, Perry, Marc D., Xiang, Qian, Zhang, Fan, Zhang, Junjun, Bailey, Peter, Erkek, Serap, Hoadley, Katherine A., Hou, Yong, Huska, Matthew R., Kilpinen, Helena, Korbel, Jan O., Marin, Maximillian G., Markowski, Julia, Nandi, Tannistha, Pan-Hammarström, Qiang ... von Mering, Christian (2020). Genomic basis for RNA alterations in cancer. Nature, 578 (7793), 129-136. doi: 10.1038/s41586-020-1970-0
2020
Journal Article
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Yuan, Yuan, Ju, Young Seok, Kim, Youngwook, Li, Jun, Wang, Yumeng, Yoon, Christopher J., Yang, Yang, Martincorena, Inigo, Creighton, Chad J., Weinstein, John N., Xu, Yanxun, Han, Leng, Kim, Hyung-Lae, Nakagawa, Hidewaki, Park, Keunchil, Campbell, Peter J., Liang, Han, Aaltonen, Lauri A., Abascal, Federico, Abeshouse, Adam, Aburatani, Hiroyuki, Adams, David J., Agrawal, Nishant, Ahn, Keun Soo, Ahn, Sung-Min, Aikata, Hiroshi, Akbani, Rehan, Akdemir, Kadir C., Al-Ahmadie, Hikmat ... von Mering, Christian (2020). Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nature Genetics, 52 (3), 342-352. doi: 10.1038/s41588-019-0557-x
2020
Book Chapter
Columnar cell lesions
Cummings, Margaret C., Simpson, Peter T. and Lakhani, Sunil R. (2020). Columnar cell lesions. Breast Pathology. Encyclopedia of Pathology. (pp. 71-79) edited by Anna Sapino and Janina Kulka. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-62539-3
2019
Journal Article
Homologous recombination DNA repair defects in PALB2-associated breast cancers
Li, Anqi, Geyer, Felipe C., Blecua, Pedro, Lee, Ju Youn, Selenica, Pier, Brown, David N., Pareja, Fresia, Lee, Simon S. K., Kumar, Rahul, Rivera, Barbara, Bi, Rui, Piscuoglio, Salvatore, Wen, Hannah Y., Lozada, John R., Gularte-Mérida, Rodrigo, Cavallone, Luca, Aghmesheh, Morteza, Amor, David, Andrews, Leslie, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Blackburn, Anneke, Bogwitz, Michael, Brown, Melissa, Burgess, Matthew, Burke, Jo, Butow, Phyllis, Caldon, Liz ... Reis-Filho, Jorge S. (2019). Homologous recombination DNA repair defects in PALB2-associated breast cancers. npj Breast Cancer, 5 (1) 23. doi: 10.1038/s41523-019-0115-9
2019
Journal Article
Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)
Li, Anqi, Geyer, Felipe C., Blecua, Pedro, Lee, Ju Youn, Selenica, Pier, Brown, David N., Pareja, Fresia, Lee, Simon S. K., Kumar, Rahul, Rivera, Barbara, Bi, Rui, Piscuoglio, Salvatore, Wen, Hannah Y., Lozada, John R., Gularte-Mérida, Rodrigo, Cavallone, Luca, Aghmesheh, Morteza, Amor, David, Andrews, Leslie, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Blackburn, Anneke, Bogwitz, Michael, Brown, Melissa, Burgess, Matthew, Burke, Jo, Butow, Phyllis, Caldon, Liz ... Reis-Filho, Jorge S. (2019). Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9). npj Breast Cancer, 5 (1) 44. doi: 10.1038/s41523-019-0140-8
2019
Journal Article
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
McCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Luca, Xavier M., Kalita-de Croft, Priyakshi, Dalley, Andrew J., Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig is a multigene predictor of outcome in invasive lobular carcinoma. npj Breast Cancer, 5 (1) 18, 18. doi: 10.1038/s41523-019-0113-y
2019
Journal Article
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
Nones, K., Johnson, J., Newell, F., Patch, A. M., Thorne, H., Kazakoff, S. H., de Luca, X. M., Parsons, M. T., Ferguson, K., Reid, L. E., McCart Reed, A. E., Srihari, S., Lakis, V., Davidson, A. L., Mukhopadhyay, P., Holmes, O., Xu, Q., Wood, S., Leonard, C., The Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab), The Australian Breast Cancer Tissue Bank (ABCTB), The Brisbane Breast Bank (BBB), Beesley, J., Harris, J. M., Barnes, D., Degasperi, A., Ragan, M. A., Spurdle, A. B., Khanna, K. K. ... Simpson, P. T. (2019). Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. Annals of Oncology, 30 (7) mdz132, 1071-1079. doi: 10.1093/annonc/mdz132
2019
Journal Article
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Ferreira, Manuel A., Gamazon, Eric R., Al-Ejeh, Fares, Aittomaki, Kristiina, Andrulis, Irene L., Anton-Culver, Hoda, Arason, Adalgeir, Arndt, Volker, Aronson, Kristan J., Arun, Banu K., Asseryanis, Ella, Azzollini, Jacopo, Balmana, Judith, Barnes, Daniel R., Barrowdale, Daniel, Beckmann, Matthias W., Behrens, Sabine, Benitez, Javier, Bermisheva, Marina, Bialkowska, Katarzyna, Blomqvist, Carl, Bogdanova, Natalia, Bojesen, Stig E., Bolla, Manjeet K., Borg, Ake, Brauch, Hiltrud, Brenner, Hermann, Broeks, Annegien, Burwinkel, Barbara ... Yip, Desmond (2019). Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications, 10 (1) 1741. doi: 10.1038/s41467-018-08053-5
2019
Journal Article
The circular RNome of primary breast cancer
Smid, Marcel, Wilting, Saskia M., Uhr, Katharina, Rodriguez-Gonzalez, F. German, de Weerd, Vanja, Prager-Van der Smissen, Wendy J. C., van der Vlugt-Daane, Michelle, van Galen, Anne, Nik-Zainal, Serena, Butler, Adam, Martin, Sancha, Davies, Helen R., Staaf, Johan, van de Vijver, Marc J., Richardson, Andrea L., MacGrogan, Gaeten, Salgado, Roberto, van den Eynden, Gert G. G. M., Purdie, Colin A., Thompson, Alastair M., Caldas, Carlos, Span, Paul N., Sweep, Fred C. G. J., Simpson, Peter T., Lakhani, Sunil R., Van Laere, Steven, Desmedt, Christine, Paradiso, Angelo, Eyfjord, Jorunn ... Martens, John W. M. (2019). The circular RNome of primary breast cancer. Genome Research, 29 (3), 356-366. doi: 10.1101/gr.238121.118
2019
Journal Article
Diff-Quik cytology smears from endobronchial ultrasound transbronchial needle aspiration lymph node specimens as a source of DNA for next-generation sequencing instead of cell blocks
Fielding, David, Dalley, Andrew J., Bashirzadeh, Farzad, Singh, Mahendra, Nandakumar, Lakshmy, McCart Reed, Amy E., Black, Debra, Kazakoff, Stephen, Pearson, John V., Nones, Katia, Waddell, Nicola, Lakhani, Sunil R. and Simpson, Peter T. (2019). Diff-Quik cytology smears from endobronchial ultrasound transbronchial needle aspiration lymph node specimens as a source of DNA for next-generation sequencing instead of cell blocks. Respiration, 97 (6), 1-14. doi: 10.1159/000495661
2019
Journal Article
Erratum: Author correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature (2016) 534 7605 (47-54))
Nik-Zainal, Serena, Davies, Helen, Staaf, Johan, Ramakrishna, Manasa, Glodzik, Dominik, Zou, Xueqing, Martincorena, Inigo, Alexandrov, Ludmil B., Martin, Sancha, Wedge, David C., Van Loo, Peter, Ju, Young Seok, Smid, Marcel, Brinkman, Arie B., Morganella, Sandro, Aure, Miriam R., Lingjærde, Ole Christian, Langerød, Anita, Ringnér, Markus, Ahn, Sung-Min, Boyault, Sandrine, Brock, Jane E., Broeks, Annegien, Butler, Adam, Desmedt, Christine, Dirix, Luc, Dronov, Serge, Fatima, Aquila, Foekens, John A. ... Stratton, Michael R. (2019). Erratum: Author correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature (2016) 534 7605 (47-54)). Nature, 566 (7742), E1-E1. doi: 10.1038/s41586-019-0883-2
Funding
Current funding
Supervision
Availability
- Associate Professor Peter Simpson is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Breast cancer metastasis prediction via machine learning and spatial cellular pathology
Associate Advisor
Other advisors: Dr Nan Ye, Dr Quan Nguyen
-
Master Philosophy
Applications of Molecular Genetics in Translational Breast Cancer Research
Associate Advisor
Other advisors: Associate Professor Amy McCart Reed, Professor Sunil Lakhani
-
Doctor Philosophy
Investigating therapeutic vulnerabilities in breast cancer.
Associate Advisor
Other advisors: Professor Sunil Lakhani, Associate Professor Amy McCart Reed
-
Doctor Philosophy
Developing optimal transport models for spatial and single cell data to understand cancer progression
Associate Advisor
Other advisors: Professor Jessica Mar, Dr Quan Nguyen
-
Doctor Philosophy
Circulating biomarkers in invasive lobular breast carcinoma
Associate Advisor
Other advisors: Professor Sunil Lakhani, Associate Professor Amy McCart Reed
Completed supervision
-
2025
Doctor Philosophy
Studies on the utility of Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS TBNA) samples in novel investigations of lung cancer genomics, and immune responses
Principal Advisor
Other advisors: Professor Sunil Lakhani
-
2021
Doctor Philosophy
Multi-omics: Leveraging omics data integration to identify dysregulated biology in breast cancer
Principal Advisor
Other advisors: Associate Professor Amy McCart Reed, Dr Katia Nones
-
2018
Doctor Philosophy
Genomic and transcriptomic biomarkers of prognosis in invasive lobular breast cancer.
Principal Advisor
Other advisors: Associate Professor Amy McCart Reed, Professor Sunil Lakhani
-
2016
Doctor Philosophy
Intratumour heterogeneity in the development and progression of breast cancer
Principal Advisor
Other advisors: Associate Professor Amy McCart Reed, Professor Sunil Lakhani
-
2016
Doctor Philosophy
Computational analysis of DNA repair pathways in breast cancer
Associate Advisor
Other advisors: Honorary Professor Kum Kum Khanna
-
2016
Doctor Philosophy
Identification of new prognostic biomarker for triple negative breast cancer
Associate Advisor
Other advisors: Dr Jodi Saunus, Professor Sunil Lakhani
-
2013
Doctor Philosophy
Clinical-Pathological and Molecular Analysis to Understand Breast Cancer Progression
Associate Advisor
Other advisors: Professor Sunil Lakhani
-
2013
Doctor Philosophy
A Search For Novel Cancer Susceptibility Genes
Associate Advisor
Other advisors: Professor Sunil Lakhani, Professor Melissa Brown
Media
Enquiries
Contact Associate Professor Peter Simpson directly for media enquiries about their areas of expertise.
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: